| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 9601006 | Clinical Oncology | 2005 | 7 Pages | 
Abstract
												We suggest that nuclear localisation of GSTÏ is associated with drug resistance. The nuclear localisation of GSTÏ in tumour cells is a useful prognosticator, and may contribute to the selection of anticancer drugs for gynaecological cancers.
											Keywords
												
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Oncology
												
											Authors
												Y. Soh, S. Goto, M. Kitajima, S. Moriyama, K. Kotera, T. Nakayama, H. Nakajima, T. Kondo, T. Ishimaru, 
											